OpenAlex
PricingAboutJobs
Log inGet started
Work

Nivolumab for the treatment of hepatocellular carcinoma

HTML

Year: 2018
Type: review
Source: Expert Review of Anticancer Therapy
DOI: 10.1080/14737140.2018.1535315
Authors: Fabian Finkelmeier, Oliver Waidmann, Joerg Trojan
Institutions: Goethe University Frankfurt, University Hospital Frankfurt
Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: nivolumab, hepatocellular carcinoma, immune checkpoint inhibitors, anti-PD-1 monoclonal antibody, immunotherapy, second-line therapy, sorafenib, pembrolizumab, atezolizumab, durvalumab, tislelizumab, advanced liver cancer
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2897963483
FWCI: 1.928
Cites: 35
Cited by: 173
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security